Vitamin D Metabolism, Mechanism of Action, and Clinical Applications

Slides:



Advertisements
Similar presentations
Halogen Bonds Form the Basis for Selective P-TEFb Inhibition by DRB Sonja Baumli, Jane A. Endicott, Louise N. Johnson Chemistry & Biology Volume 17, Issue.
Advertisements

Development of Antibiotic Activity Profile Screening for the Classification and Discovery of Natural Product Antibiotics Weng Ruh Wong, Allen G. Oliver,
Proteasome Inhibition by Fellutamide B Induces Nerve Growth Factor Synthesis John Hines, Michael Groll, Margaret Fahnestock, Craig M. Crews Chemistry &
Biocompatible Quantum Dots for Biological Applications Sandra J. Rosenthal, Jerry C. Chang, Oleg Kovtun, James R. McBride, Ian D. Tomlinson Chemistry &
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates Bradley Croy Doak, Bj ӧ rn Over, Fabrizio Giordanetto, Jan Kihlberg.
Glycosidase Inhibition by Macrolide Antibiotics Elucidated by STD-NMR Spectroscopy Ali Sadeghi-Khomami, Michael D. Lumsden, David L. Jakeman Chemistry.
Daniel Bikle, John Adams, and Sylvia Christakos
Vitamin D for your patients with chronic hepatitis C?
Redefining vitamin D insufficiency
The Physiology and Pathophysiology of Vitamin D
(A) Pathway of vitamin D metabolism
Nucleosomes and Cisplatin
Deon Wolpowitz, MD, PhD, Barbara A. Gilchrest, MD 
Volume 22, Issue 5, Pages v-vi (May 2015)
Vitamin D Insufficiency
Electrolyte Disorders Associated With Cancer
Now Playing: Farnesol in the Biofilm
The Physiology and Pathophysiology of Vitamin D
Volume 73, Issue 1, Pages 3-5 (January 2008)
Enzyme Annotation with Chemical Tools
New Light on Methylthiolation Reactions
Tailor-Made Peptide Synthetases
Fibroblast Growth Factor 23 and CKD Prognosis
Nucleosomes and Cisplatin
Homing in on bile acid physiology
Antibiotics: A New Hope
Foundations for Directed Alkaloid Biosynthesis
Nature’s Strategy for Catalyzing Diels-Alder Reaction
In Search of the Missing Ligands for TetR Family Regulators
Adding Specificity to Artificial Transcription Activators
Reassembling Biological Machinery In Vitro
Role of vitamin D in uterine fibroid biology
Epithelial Homeostasis: A Piezo of the Puzzle
JAK3 Specific Kinase Inhibitors: When Specificity Is Not Enough
Activity-Based Profiling of 2-Oxoglutarate Oxygenases
M. Fukagawa, S. Nakanishi, J.J. Kazama  Kidney International 
Chapter 65 - The Hormonal Regulation of Calcium Metabolism
Targeting the Undruggable Proteome: The Small Molecules of My Dreams
Reassembling Biological Machinery In Vitro
No Need To Be Pure: Mix the Cultures!
Another Shp on the Horizon for Bile Acids
Vitamin D for your patients with chronic hepatitis C?
Volume 79, Pages S20-S23 (April 2011)
Vitamin D: The Iceberg Nutrient
Florian Lang, Michael Föller  Kidney International 
Now Playing: Farnesol in the Biofilm
HAT Trick: p300, Small Molecule, Inhibitor
BCR-ABL1 Kinase: Hunting an Elusive Target with New Weapons
Volume 21, Issue 8, Pages v-vi (August 2014)
Foundations for Directed Alkaloid Biosynthesis
Discrimination between Two Endocannabinoids
Redesigning the Architecture of the Base Pair: Toward Biochemical and Biological Function of New Genetic Sets  Andrew T. Krueger, Eric T. Kool  Chemistry.
Nature’s Strategy for Catalyzing Diels-Alder Reaction
L-DOPA Ropes in tRNAPhe
Volume 7, Issue 6, Pages R147-R151 (June 2000)
Vitamin D: Mechanisms of Action and Clinical Applications
Volume 75, Issue 9, Pages (May 2009)
Fibroblast growth factor 23: the making of a hormone
Volume 21, Issue 9, Pages (September 2014)
Phosphate and the parathyroid
Volume 82, Issue 10, Pages (November 2012)
Tools to Tackle Protein Acetylation
The ins and outs of phosphate homeostasis
Homing in on bile acid physiology
Marta Christov, Harald Jüppner  Kidney International 
Ronen Levi, Justin Silver  Kidney International 
Volume 21, Issue 9, Pages (September 2014)
Volume 18, Issue 5, Pages R198-R202 (March 2008)
Untangling Klotho's Role in Calcium Homeostasis
Volume 22, Issue 4, Pages vii-viii (April 2015)
Presentation transcript:

Vitamin D Metabolism, Mechanism of Action, and Clinical Applications Daniel D. Bikle  Chemistry & Biology  Volume 21, Issue 3, Pages 319-329 (March 2014) DOI: 10.1016/j.chembiol.2013.12.016 Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 1 The Production and Metabolism of D2 and D3 D3 is produced in the skin from 7-DHC in a nonenzymatic process in which the B ring is broken by UVB radiation, and the pre-D3 formed isomerizes to D3 in a thermo-sensitive process. D3 is converted to 25OHD3 in the liver and elsewhere by a number of enzymes of which CYP2R1 is the most important. The regulation of this step is modest at best. The kidney and other tissues metabolize 25OHD to the active metabolite 1,25(OH)2D3 or the first step in the catabolic process 24,25(OH)2D3. The enzymes responsible, CYP27B1 and CYP24A1, respectively, are tightly controlled. Although the regulation differs in different tissues, in the kidney, CYP27B1 is stimulated by PTH and inhibited by FGF23 and high calcium (Ca) and phosphate (P). The regulation of CYP24A1 is just the opposite. 1,25(OH)2D3 also regulates its own production directly and by inhibiting PTH production, stimulating FGF23 production, and inducing CYP24A1. Chemistry & Biology 2014 21, 319-329DOI: (10.1016/j.chembiol.2013.12.016) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 2 Clinically Used Analogs of 1,25(OH)2 The structures of various vitamin D analogs currently in use clinically. Chemistry & Biology 2014 21, 319-329DOI: (10.1016/j.chembiol.2013.12.016) Copyright © 2014 Elsevier Ltd Terms and Conditions